Literature DB >> 9052856

Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax.

H Masutani1, K Hirota, T Sasada, Y Ueda-Taniguchi, Y Taniguchi, H Sono, J Yodoi.   

Abstract

Adult T-cell leukemia derived factor (ADF)/human thioredoxin (TRX), which has thiol reducing and radical scavenging activities, plays an essential role on cellular protection against oxidative stress and cell death. TRX itself is induced by various oxidative stress as well as the Human T-cell lymphotropic virus type I (HTLV-I) Tax protein. To investigate the mechanism of this induction, the promoter region of the TRX gene was analyzed. Chloramphenicol acetyltransferase (CAT) reporter constructs containing the TRX promoter sequences responded to the overexpression of the Tax protein, whereas various oxidative agents activated the TRX promoter through a newly identified oxidative responsive element. Moreover, TRX was translocated from the cytoplasm into the nucleus by ultraviolet irradiation, suggesting its possible role on sensing and transducing oxidative signals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9052856     DOI: 10.1016/s0165-2478(96)02651-x

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  11 in total

Review 1.  Mechanisms of viral pathogenesis in rheumatic disease.

Authors:  A Perl
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

2.  Cynoglossus semilaevis thioredoxin: a reductase and an antioxidant with immunostimulatory property.

Authors:  Jin-sheng Sun; Yong-xin Li; Li Sun
Journal:  Cell Stress Chaperones       Date:  2012-01-18       Impact factor: 3.667

Review 3.  HTLV-1 p13, a small protein with a busy agenda.

Authors:  Micol Silic-Benussi; Roberta Biasiotto; Vibeke Andresen; Genoveffa Franchini; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Mol Aspects Med       Date:  2010-03-21

Review 4.  Redox-based regulation of signal transduction: principles, pitfalls, and promises.

Authors:  Yvonne M W Janssen-Heininger; Brooke T Mossman; Nicholas H Heintz; Henry J Forman; Balaraman Kalyanaraman; Toren Finkel; Jonathan S Stamler; Sue Goo Rhee; Albert van der Vliet
Journal:  Free Radic Biol Med       Date:  2008-03-27       Impact factor: 7.376

5.  Induction of reactive oxygen species by human T-cell leukemia virus type 1 tax correlates with DNA damage and expression of cellular senescence marker.

Authors:  Takao Kinjo; Julia Ham-Terhune; Jean-Marie Peloponese; Kuan-Teh Jeang
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

Review 6.  Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection.

Authors:  Meijuan Zhang; Chengrui An; Yanqin Gao; Rehana K Leak; Jun Chen; Feng Zhang
Journal:  Prog Neurobiol       Date:  2012-09-29       Impact factor: 11.685

7.  Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load.

Authors:  C Elbim; S Pillet; M H Prevost; A Preira; P M Girard; N Rogine; H Matusani; J Hakim; N Israel; M A Gougerot-Pocidalo
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Penaeus monodon thioredoxin restores the DNA binding activity of oxidized white spot syndrome virus IE1.

Authors:  Jiun-Yan Huang; Wang-Jing Liu; Han-Ching Wang; Der-Yen Lee; Jiann-Horng Leu; Hao-Ching Wang; Mong-Hsun Tsai; Shih-Ting Kang; I-Tung Chen; Guang-Hsiung Kou; Geen-Dong Chang; Chu-Fang Lo
Journal:  Antioxid Redox Signal       Date:  2012-04-16       Impact factor: 8.401

9.  Direct inhibition of RNAse T2 expression by the HTLV-1 viral protein Tax.

Authors:  Nicholas Polakowski; Hongjin Han; Isabelle Lemasson
Journal:  Viruses       Date:  2011-08-18       Impact factor: 5.048

10.  Reduced levels of reactive oxygen species correlate with inhibition of apoptosis, rise in thioredoxin expression and increased bovine leukemia virus proviral loads.

Authors:  Amel Baya Bouzar; Mathieu Boxus; Arnaud Florins; Carole François; Michal Reichert; Luc Willems
Journal:  Retrovirology       Date:  2009-11-10       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.